THERAPY Risk of metformin use in patients with T2DM and advanced CKD

被引：9
|
作者：
Schernthaner, Guntram [1 ]
Schernthaner-Reiter, Marie Helene [2 ]
机构：
[1] Rudolfstiftung Hosp, Dept Med 1, A-1030 Vienna, Austria
[2] Med Univ Vienna, Dept Internal Med 3, Clin Div Endocrinol & Metab, A-1090 Vienna, Austria
来源：
NATURE REVIEWS ENDOCRINOLOGY | 2015年 / 11卷 / 12期
关键词：
KIDNEY-DISEASE; MORTALITY;
D O I：
10.1038/nrendo.2015.132
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In a new study published in The Lancet Diabetes & Endocrinology, metformin use is associated with significantly increased all-cause mortality in patients with type 2 diabetes mellitus and stage 5 chronic kidney disease (CKD). The findings support current recommendations that metformin should not be used in patients with stage 5 CKD.
引用
收藏
页码：697 / 698
页数：2
相关论文
共 50 条
  • [41] The Influence of MTHFR C677T Variants on Neuropathy Risk Among T2dm Patients Receiving Monotherapy Metformin
    Yanuar, Michael Resta Surya
    Istyastono, Enade Perdana
    Virginia, Dita Maria
    [J]. INDONESIAN JOURNAL OF PHARMACY, 2024, 35 (01): : 147 - 153
  • [42] Some sulfonylureas increase risk of MACE in patients with T2DM
    [J]. Reactions Weekly, 2022, 1899 (1) : 11 - 11
  • [43] Safety and Tolerability of Linagliptin and Metformin in Combination for Patients with Type 2 Diabetes Mellitus (T2DM)
    Ross, Stuart A.
    Haak, Thomas
    Patel, Sanjay
    Thiemann, Sandra
    Schumacher, Helmut
    Meinicke, Thomas
    [J]. DIABETES, 2014, 63 : A277 - A277
  • [44] Metformin upregulates mitophagy in patients with T2DM: A randomized placebo-controlled study
    Bhansali, Shipra
    Bhansali, Anil
    Dutta, Pinaki
    Walia, Rama
    Dhawan, Veena
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (05) : 2832 - 2846
  • [45] Insulin Secretion and Sensitivity Pattern Is Different in patients With T2DM Only or Patients With T2DM and NAFLD
    Pan, Xiaoyu
    Liu, Qing
    Song, Kexiu
    Chai, Shangyu
    Li, Fei
    Huang, Yueye
    Bhavna, Bhavna
    Jhummon, Navina Priya
    Qu, Shen
    [J]. DIABETES, 2013, 62 : A492 - A492
  • [46] The Usage of Metformin Despite of Existing Contraindications in Type 2 Diabetes Mellitus (T2DM) Patients
    Kosmalski, Marcin
    Drozdowska, Agata
    Drzewoski, Jozef
    [J]. DIABETES, 2011, 60 : A311 - A312
  • [47] GLYCEMIC CONTROL IN PATIENTS WITH T2DM TREATED WITH SULFONYLUREAS ALONE OR IN COMBINATION WITH METFORMIN, ARGENTINA
    Monti, C., I
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A919 - A919
  • [48] Effect of metformin on gut microbiota imbalance in patients with T2DM, and the value of probiotic supplementation
    Li, Lu
    Chen, Yanli
    Tang, Zhipeng
    You, Yan
    Guo, Yang
    Liao, Yong
    [J]. ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2024, 52 (04) : 84 - 90
  • [49] Two-year efficacy of pioglitazone versus gliclazide addition to metformin therapy in T2DM
    Edwards, G
    Urquhart, R
    Moules, I
    Tan, MH
    Mariz, S
    [J]. DIABETES, 2004, 53 : A475 - A475
  • [50] Comparative analysis of the transcriptome of T2DM Bama mini-pigs with T2DM patients
    Yan, Xueyu
    Si, Jinglei
    Zhong, Fangjie
    Wu, Yanjun
    Jiang, Qinyang
    Guo, Yafen
    Yang, Xiurong
    Liang, Jing
    Lan, Ganqiu
    [J]. INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2022, 42 (02) : 236 - 244
12345